Latest Conference Articles

May 18th 2022, 1:00pm

Educated Patient® MPN Summit: May 7, 2022

Watch Dr. Jamile Shammo, Dr. Aaron Gerds and Dr. Bart Scott, answer questions during the diagnoses and treatment panel during the CURE Educated Patient MPN Summit.

May 17th 2022, 1:00pm

Educated Patient® MPN Summit: May 7, 2022

Watch Dr. Bart Scott, from Fred Hutchinson Cancer Center, discuss current treatment options, during the CURE Educated Patient MPN Summit.

May 16th 2022, 1:00pm

Educated Patient® MPN Summit: May 7, 2022

Watch Dr. Aaron Gerds, from Cleveland Clinic Taussig Cancer Institute, discuss approaches to diagnosing and assessing symptoms, during the CURE Educated Patient MPN Summit.

May 1st 2022, 2:00pm

Educated Patient® Kidney Cancer Summit: April 9, 2022

Watch Dr. Thomas Hutson, Dr. Saby George, Dr. Jeff Yorio and Louise Gunter answer questions about combination therapy, during the CURE Educated Patient Kidney Cancer Summit.

April 30th 2022, 2:00pm

Educated Patient® Kidney Cancer Summit: April 9, 2022

Watch Louise Gunter, from Texas Oncology, discuss IO/TKI-related side effects, during the CURE Educated Patient Kidney Cancer Summit.

April 29th 2022, 1:00pm

Educated Patient® Kidney Cancer Summit: April 9, 2022

Watch Dr. Jeff Yorio, from Texas Oncology, discuss treatment with the combination of immunotherapy and tyrosine kinase inhibitors, during the CURE Educated Patient Kidney Cancer Summit.

April 28th 2022, 3:43pm

Educated Patient® Kidney Cancer Summit: April 9, 2022

Watch Dr. Saby George, from Roswell Park Comprehensive Cancer Center, discuss treatment with the combination of immunotherapies, during the CURE Educated Patient Kidney Cancer Summit.

April 27th 2022, 1:00pm

Educated Patient® Kidney Cancer Summit: April 9, 2022

Watch Dr. Thomas Hutson, Louise Gunter and Meryl Uranga discuss communicating with a care team about treatment with immunotherapy combined with tyrosine kinase inhibitors, during the CURE Educated Patient Kidney Cancer Summit.

April 26th 2022, 1:00pm

Educated Patient® Kidney Cancer Summit: April 9, 2022

Watch Dr. Thomas Hutson, Louise Gunter and Meryl Uranga discuss side effects and dose reductions after treatment with immunotherapy combined with tyrosine kinase inhibitors, during the CURE Educated Patient Kidney Cancer Summit.

April 25th 2022, 1:00pm

Educated Patient® Kidney Cancer Summit: April 9, 2022

Watch Dr. Thomas Hutson, Louise Gunter and Meryl Uranga discuss the treatment of combining immunotherapy with tyrosine kinase inhibitors, during the CURE Educated Patient Kidney Cancer Summit.

April 24th 2022, 2:00pm

Educated Patient® Kidney Cancer Summit: April 9, 2022

Watch Dr. Thomas Hutson, Dr. Jose Karam, Dr, Naomi Haas, and Kiran Kehoe answer questions about frontline therapy during the CURE Educated Patient Kidney Cancer Summit.

April 23rd 2022, 2:00pm

Educated Patient® Kidney Cancer Summit: April 9, 2022

Watch Dr. Naomi Haas, from Abramson Cancer Center, discuss adjuvant therapy options, during the CURE Educated Patient Kidney Cancer Summit.

April 22nd 2022, 1:00pm

Educated Patient® Kidney Cancer Summit: April 9, 2022

Watch Dr. Jose Karam, from The University of Texas MD Anderson Cancer Center, discuss surgical options, during the CURE Educated Patient Kidney Cancer Summit.

April 21st 2022, 1:00pm

Watch Dr. Vitaly Margulis, Dr. Rana Mckay and Kwame Garrett-Price answer questions about kidney cancer diagnoses during the CURE Educated Patient Kidney Cancer Summit.

April 20th 2022, 1:00pm

Educated Patient® Kidney Cancer Summit: April 9, 2022

Watch Dr. Rana R. McKay, from the University of California San Diego, discuss genetic testing in renal cell carcinoma during the CURE Educated Patient Kidney Cancer Summit.

April 19th 2022, 1:00pm

Educated Patient® Kidney Cancer Summit: April 9, 2022

Watch Dr. Vitaly Margulis, from UT Southwestern Medical Center, discuss staging, during the CURE Educated Patient Kidney Cancer Summit.

April 9th 2022, 2:00pm

Educated Patient® Multiple Myeloma Summit: March 12, 2022

Watch Kristie L. Kahl, with Sham Mailankody, MBBS; Cesar Rodriguez, MD; and Lynn Steele, discuss new therapies on the horizon, during the CURE Educated Patient Multiple Myeloma Summit.

April 8th 2022, 1:00pm

Educated Patient® Multiple Myeloma Summit: March 12, 2022

Watch Dr. Cesar Rodriguez, of the Multiple Myeloma Program at the Ichan School of Medicine at Mount Sinai, discuss upcoming FDA approvals in the space, during the CURE Educated Patient Multiple Myeloma Summit.

April 7th 2022, 1:00pm

Educated Patient® Multiple Myeloma Summit: March 12, 2022

Watch Dr. Sham Mailankody, from Memorial Sloan Kettering Cancer Center, discuss CAR and BiTE therapy, during the CURE Educated Patient Multiple Myeloma Summit.

April 6th 2022, 1:00pm

Educated Patient® Multiple Myeloma Summit: March 12, 2022

Watch Dr. Saad Z. Usmani, Dr. Ben Marcus and Stan Wagner discuss their participation in the Moving Mountains for Multiple Myeloma program, during the CURE Educated Patient Multiple Myeloma Summit.

April 5th 2022, 1:00pm

Educated Patient® Multiple Myeloma Summit: March 12, 2022

Watch Kristie L. Kahl, Donna and Jack McNutt, Dr. Noopur Raje, and Grace Allison, discuss treating myeloma long term, during the CURE Educated Patient Multiple Myeloma Summit.

April 4th 2022, 1:00pm

Educated Patient® Multiple Myeloma Summit: March 12, 2022

Watch Dr. Saad Z. Usmani, Dr. Krina K. Patel, Dr. Noa Biran, and Jenny Ahlstrom, answer audience Q&A during the CURE Educated Patient Multiple Myeloma Summit.

April 3rd 2022, 2:00pm

Educated Patient® Multiple Myeloma Summit: March 12, 2022

Watch Dr. Noa Biran, an associate professor of medicine in the division of multiple myeloma at The John Theurer Cancer Center at Hackensack University Medical Center, discuss treatment for relapsed/refractory myeloma.

April 2nd 2022, 2:00pm

Educated Patient® Multiple Myeloma Summit: March 12, 2022

Watch Dr. Krina K. Patel, an associate professor and center medical director for the Department of Lymphoma-Myeloma at The University of Texas MD Anderson Cancer Center discuss treatment for newly diagnosed myeloma.

April 1st 2022, 1:00pm

Educated Patient® Multiple Myeloma Summit: March 12, 2022

Watch Saad Z. Usmani, MD, MBA, with Carlyn Rose Tan, MD; Neha S. Korde, MD; and Kenny Capps answer audience Q&A during the CURE Educated Patient Multiple Myeloma Summit.

March 31st 2022, 1:00pm

Educated Patient® Multiple Myeloma Summit: March 12, 2022

Watch Dr. Carlyn Rose Tan, an assistant attending in myeloma service at Memorial Sloan Kettering Cancer Center, present on risk stratification for newly diagnosed patients.

March 30th 2022, 1:00pm

Educated Patient® Multiple Myeloma Summit: March 12, 2022

Watch Dr. Neha S. Korde, an assistant professor in multiple myeloma service in the Division of Hematology at Memorial Sloan Kettering Cancer Center, present on MGUS/smoldering myeloma.

March 23rd 2022, 7:00pm

SGO Annual Meeting on Women's Cancer

There were no major differences in survival when comparing intravenous and intraperitoneal chemotherapy plus Avastin in patients with advanced ovarian cancer, research shows.

March 22nd 2022, 3:00pm

SGO Annual Meeting on Women's Cancer

“These results position mirvetuximab soravtansine to become a practice-changing, biomarker-driven, standard-of-care treatment option for patients with (high folate receptor-alpha)-positive, platinum-resistant ovarian cancer,” noted one of the study authors.

March 22nd 2022, 12:30pm

SGO Annual Meeting on Women's Cancer

Zejula plus Avastin led to promising progression-free survival rates with no new side effects for patients with newly diagnosed, advanced ovarian cancer.